Healthcare / Solutions
Wholesale point-of-care STI testing, sized for your practice.
Independent clinics, multi-site networks, FQHCs, and public-health programs use UroSure for same-visit results from a single urine specimen.
Buyer profiles
Three buyer tiers.
Tier 01
Independent practice
- 1–3 sites
- Owner-operator decision making
- Cases shipped within five business days
- Standard wholesale terms
Tier 02
Multi-site network or system
- 4–49 sites
- Centralized procurement
- Volume tier pricing
- Net-30 invoicing on approved credit
Tier 03
Health department, FQHC, government
- Multi-site, grant-funded, or contract procurement
- SAM.gov UEI and W-9 available on request
- Capability statement available for federal and state buyers
- GPO contract status: contact sales for current availability
Procurement
Procurement and contracting.
- 01 Standard wholesale agreement, one page.
- 02 Volume pricing tiers at 1, 5, 25, and 100+ cases.
- 03 Net-30 and Net-60 terms on approved credit.
- 04 W-9 and product spec sheet available on request.
- 05 SAM.gov registration and CAGE/UEI for federal and state buyers.
- 06 GPO contract status and distributor relationships: contact sales for current details.
Funding sources
Compatible with nonprofit and grant-funded budgets.
For nonprofit and grant-funded buyers, UroSure is compatible with the following program budgets.
- ● Title X family planning
- ● Ryan White Part C
- ● HRSA Section 330 (FQHC)
- ● HRSA Look-Alike
- ● 340B Drug Pricing Program
- ● CDC PS21-2102 (STI)
- ● SAMHSA grants for MAT and CCBHC
- ● State and county public health contracts
Compatibility statements describe budget compatibility, not endorsement. The client confirms approved-buyer status before publication.
Resources
Clinical resources.
- 01 Product spec sheet (PDF) Available on request
- 02 Instructions for use (IFU) Available on request
- 03 CPT coding reference card Available on request
- 04 ROI calculator Available on request
- 05 Workflow card (printable, one page) Available on request
- 06 QC log template Available on request
- 07 Sample patient receipt for cash-pay practices Available on request
- 08 Sample order form Available on request
Compliance
Compliance and regulatory.
- Regulatory use
- For In Vitro Diagnostic Use Only. FDA-listed IVD. Preliminary screening only — positive results require confirmatory testing by an alternative laboratory method.
- CLIA classification
- Not CLIA-waived (moderate complexity). Run by clinical staff at point of care under a CLIA-certified site.
- HIPAA
- Result data does not leave the clinic; no cloud transmission required for the testing workflow.
- Manufacturer
- MobiLab. UroSure is the authorized wholesale distributor.
- Sensitivity / Specificity
- Sensitivity 88–97% across analytes; specificity 86–98%. Per-analyte figures on the homepage.
Support
Support and service.
- 01 Live phone and email support during business hours.
- 02 Virtual training included with first order.
- 03 In-service visit available for qualifying volume.
- 04 Lot deviation reporting and replacement policy.
- 05 Returns, exchanges, and damage claims policy.
Request pricing
A UroSure rep will follow up.
Tell us about your practice and we'll send wholesale pricing scoped to your volume within one business day.